The results in vivo were consistent with those researches in vitro, indicating that miR-495 overexpression could suppress HCC cells growth, and the inhibitory effect is mainly through targeting CTRP3 expression. The gene discussed is C1QTNF3; the disease is hepatocellular carcinoma.